Jasper Therapeutics (JSPR) Institutional Ownership $5.97 -0.19 (-3.12%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$6.06 +0.10 (+1.63%) As of 02/21/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)CurrentInstitutional OwnershipPercentage79.85%Number ofInstitutional Buyers(last 12 months)39TotalInstitutional Inflows(last 12 months)$65.01MNumber ofInstitutional Sellers(last 12 months)16TotalInstitutional Outflows(last 12 months)$763.56M Get JSPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data JSPR Institutional Buying and Selling by Quarter Jasper Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Woodline Partners LP245,676$5.25M0.0%-50.4%1.638% 2/17/2025 Soleus Capital Management L.P.1,494,420$31.95M2.0%+11.2%9.962% 2/17/2025 Tema Etfs LLC12,435$266K0.1%N/A0.083% 2/17/2025 Stempoint Capital LP135,244$2.89M0.7%N/A0.902% 2/17/2025 Integral Health Asset Management LLC650,000$13.90M1.2%+85.7%4.333% 2/17/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208% 2/17/2025 Deutsche Bank AG170,695$3.65M0.0%+30.0%1.138% 2/17/2025 Braidwell LP714,658$15.28M0.5%+47.9%4.764% 2/17/2025 Bank of America Corp DE287,204$6.14M0.0%-11.9%1.915% 2/17/2025 Allostery Investments LP22,000$470K0.5%N/A0.147% Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Ally Bridge Group NY LLC122,424$2.62M2.2%-69.4%0.816% 2/14/2025 Boxer Capital Management LLC350,000$7.48M0.6%N/A2.333% 2/14/2025 Jane Street Group LLC10,852$232K0.0%-18.7%0.072% 2/14/2025 Northern Trust Corp104,367$2.23M0.0%-2.4%0.696% 2/14/2025 Propel Bio Management LLC20,000$428K0.4%N/A0.133% 2/14/2025 T. Rowe Price Investment Management Inc.82,165$1.76M0.0%N/A0.548% 2/14/2025 Rock Springs Capital Management LP463,088$9.90M0.4%+0.9%3.087% 2/13/2025 Marshall Wace LLP77,722$1.66M0.0%+17.2%0.518% 2/13/2025 Mariner LLC36,794$787K0.0%-12.8%0.245% 2/13/2025 Barclays PLC18,334$392K0.0%+13.6%0.122% 2/13/2025 Russell Investments Group Ltd.247,272$5.29M0.0%+16.9%1.648% 2/13/2025 Wells Fargo & Company MN7,415$159K0.0%+106.7%0.049% 2/12/2025 Wellington Management Group LLP27,069$579K0.0%+13.9%0.180% 2/12/2025 Schroder Investment Management Group59,034$1.24M0.0%N/A0.394% 2/12/2025 JPMorgan Chase & Co.5,165$110K0.0%-68.5%0.034% 2/11/2025 EntryPoint Capital LLC10,431$223K0.1%N/A0.070% 2/11/2025 Simplify Asset Management Inc.20,000$428K0.0%N/A0.133% 1/30/2025 Rhumbline Advisers14,761$316K0.0%+12.6%0.098% 12/26/2024 JPMorgan Chase & Co.16,391$308K0.0%+239.8%0.109% 11/27/2024 Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864% 11/19/2024 Barclays PLC16,146$304K0.0%+320.7%0.108% 11/16/2024 Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704% 11/15/2024 Barclays PLC16,146$304K0.0%+320.7%0.107% 11/15/2024 Jane Street Group LLC13,354$251K0.0%N/A0.088% 11/15/2024 Wellington Management Group LLP23,759$447K0.0%N/A0.157% 11/15/2024 State Street Corp214,883$4.04M0.0%+12.3%1.423% 11/15/2024 Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872% 11/15/2024 Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365% 11/14/2024 Braidwell LP483,300$9.09M0.3%N/A3.201% 11/14/2024 Verition Fund Management LLC25,353$477K0.0%N/A0.168% Here’s how you could profit from Elon’s NVIDIA partnership (Ad)"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world. Get all the details here >>>11/14/2024 Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645% 11/14/2024 MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046% 11/13/2024 Great Point Partners LLC322,380$6.06M1.8%-19.8%2.135% 11/13/2024 BNP Paribas Financial Markets2,512$47K0.0%+208.6%0.017% 11/13/2024 FMR LLC38,361$722K0.0%N/A0.254% 10/30/2024 AlphaCentric Advisors LLC17,500$329K0.2%N/A0.116% 10/29/2024 Fernwood Investment Management LLC52,897$995K0.3%+6.9%0.351% 10/16/2024 Wolff Wiese Magana LLC3,146$59K0.0%N/A0.021% 8/14/2024 Great Point Partners LLC402,015$9.13M1.7%-1.4%2.669% 8/14/2024 Ally Bridge Group NY LLC218,614$4.96M3.0%-24.6%1.451% 8/8/2024 American Century Companies Inc.14,204$322K0.0%+27.1%0.094% 8/1/2024 Rhumbline Advisers13,231$300K0.0%N/A0.088% 7/26/2024 Bank of New York Mellon Corp32,579$740K0.0%N/A0.216% 5/29/2024 Opaleye Management Inc.435,573$12.79M2.8%-89.1%2.892% 5/20/2024 Virtu Financial LLC10,410$306K0.0%N/A0.069% 5/17/2024 Ikarian Capital LLC105,175$3.09M0.3%N/A0.698% 5/16/2024 Kingdon Capital Management L.L.C.497,000$14.59M1.6%-86.0%3.300% 5/14/2024 Qiming U.S. Ventures Management LLC928,964$27.27M30.4%-89.1%6.168% 5/14/2024 StemPoint Capital LP129,211$3.79M1.0%N/A0.858% 5/10/2024 Vanguard Group Inc.612,745$17.99M0.0%-85.0%4.069% 5/8/2024 Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530% 5/7/2024 Concurrent Investment Advisors LLC20,409$599K0.0%N/A0.136% 5/3/2024 Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080% 3/18/2024 Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720% 2/15/2024 Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717% 2/7/2024 Ieq Capital LLC54,500$43K0.0%N/A0.488% 2/7/2024 Monaco Asset Management SAM249,563$197K0.1%N/A2.236% 2/5/2024 Fernwood Investment Management LLC494,706$390K0.1%+8.8%4.433% 11/13/2023 Mariner LLC652,749$457K0.0%-8.7%0.589% 11/9/2023 Cowen AND Company LLC200,393$140K0.0%N/A0.181% 11/8/2023 Forefront Analytics LLC110,792$78K0.0%+59.7%0.100% 10/30/2023 Summit Trail Advisors LLC65,000$46K0.0%N/A0.059% 8/15/2023 Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874% 8/14/2023Jefferies Financial Group Inc.489,884$671K0.0%N/A0.444% 6/1/2023 Prelude Capital Management LLC54,500$99K0.0%N/A0.049% 5/16/2023 Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301% 5/16/2023 BVF Inc. IL9,900,000$17.92M0.7%N/A9.051% 5/15/2023 Affinity Asset Advisors LLC476,948$863K0.3%N/A0.436% 5/15/2023 Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779% 5/15/2023 RTW Investments LP2,329,809$4.22M0.1%N/A2.130% 5/12/2023 Forefront Analytics LLC30,290$55K0.0%-73.4%0.028% 5/5/2023 Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011% 5/3/2023 Jump Financial LLC33,074$60K0.0%N/A0.030% 4/25/2023 Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789% 2/13/2023 Forefront Analytics LLC114,000$55K0.0%-4.8%0.300% 2/7/2023 Fernwood Investment Management LLC454,706$220K0.1%+53.1%1.197% 11/14/2022 Forefront Analytics LLC119,800$94K0.1%+246.0%0.327% 11/9/2022 Fernwood Investment Management LLC297,080$234K0.1%N/A0.810% 5/10/2022 Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782% 5/9/2022 Forefront Analytics LLC32,550$118K0.0%N/A0.086% Elon Social Security shock? (Ad)“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One Boston based think tank believes it could have drastic impacts on your money and life in America.Get the details here.4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026% 2/15/2022 Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427% 2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576% 1/28/2022Vahanian & Associates Financial Planning Inc.25,000$196K0.2%N/A0.066% 11/16/2021 Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228% 11/15/2021 Tudor Investment Corp Et Al20,000$205K0.0%N/A0.055% 11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412% (Data available from 1/1/2016 forward) JSPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of JSPR shares? During the previous two years, 61 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($31.95M), Carlyle Group Inc. ($31.30M), Qiming U.S. Ventures Management LLC ($27.27M), Vanguard Group Inc. ($17.99M), BVF Inc. IL ($17.92M), Braidwell LP ($15.28M), and Kingdon Capital Management L.L.C. ($14.59M).Learn more on JSPR's institutional investors. What percentage of Jasper Therapeutics stock is owned by institutional investors? 79.85% of Jasper Therapeutics stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings. Which institutional investors have been buying Jasper Therapeutics stock? Of the 53 institutional investors that purchased Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($9.90M), Carlyle Group Inc. ($8.76M), Opaleye Management Inc. ($3.99M), Kingdon Capital Management L.L.C. ($3M), Ally Bridge Group NY LLC ($2.70M), Qiming U.S. Ventures Management LLC ($2.67M), and RTW Investments LP ($2.33M). How much institutional buying is happening at Jasper Therapeutics? Institutional investors have bought a total of 37,930,324 shares in the last 24 months. This purchase volume represents approximately $640.42M in transactions. Which Jasper Therapeutics major shareholders have been selling company stock? Of the 17 institutional investors that sold Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Carlyle Group Inc. ($7.70M), Qiming U.S. Ventures Management LLC ($7.59M), Opaleye Management Inc. ($3.55M), Vanguard Group Inc. ($3.48M), Kingdon Capital Management L.L.C. ($3.04M), Ally Bridge Group NY LLC ($348.37K), and Woodline Partners LP ($249.43K). How much institutional selling is happening at Jasper Therapeutics? Institutional investors have sold a total of 26,419,920 shares in the last 24 months. This volume of shares sold represents approximately $765.51M in transactions. Related Companies REGENXBIO Major Shareholders Tourmaline Bio Major Shareholders MBX Biosciences Major Shareholders Aurora Cannabis Major Shareholders Terns Pharmaceuticals Major Shareholders Foghorn Therapeutics Major Shareholders Taysha Gene Therapies Major Shareholders Cryoport Major Shareholders Annexon Major Shareholders Corvus Pharmaceuticals Major Shareholders This page (NASDAQ:JSPR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
